Načítá se...
Oligometastatic Disease in Pancreatic Cancer – How to Proceed?
BACKGROUND: Pancreatic cancer is a highly aggressive malignancy and will become the second leading cause of cancer-related death in the USA and also in Germany by 2030. Furthermore, the majority of patients with pancreatic ductal adenocarcinoma (PDAC) will present with distant metastases, limiting s...
Uloženo v:
| Vydáno v: | Visc Med |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
S. Karger GmbH
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5465679/ https://ncbi.nlm.nih.gov/pubmed/28612015 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000455027 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|